Your browser doesn't support javascript.
loading
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.
Vivas-Mejia, Pablo; Benito, Juliana Maria; Fernandez, Ariel; Han, Hee-Dong; Mangala, Lingegowda; Rodriguez-Aguayo, Cristian; Chavez-Reyes, Arturo; Lin, Yvonne G; Carey, Mark S; Nick, Alpa M; Stone, Rebecca L; Kim, Hye Sun; Claret, Francois-Xavier; Bornmann, William; Hennessy, Bryan T J; Sanguino, Angela; Peng, Zhengong; Sood, Anil K; Lopez-Berestein, Gabriel.
Affiliation
  • Vivas-Mejia P; Department of Experimental Therapeutics, Center for RNAi and non-coding-RNA, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Clin Cancer Res ; 16(1): 184-94, 2010 Jan 01.
Article in En | MEDLINE | ID: mdl-20028751
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Piperazines / Pyrimidines / Mitogen-Activated Protein Kinase 8 Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Piperazines / Pyrimidines / Mitogen-Activated Protein Kinase 8 Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Animals / Female / Humans / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States